Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

NCT02601287 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02601287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
July 31, 2016
Enrollment
168 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urinary incontinence